Literature DB >> 21777810

Reversible SUMOylation of TBL1-TBLR1 regulates β-catenin-mediated Wnt signaling.

Hyo-Kyoung Choi1, Kyung-Chul Choi, Jung-Yoon Yoo, Meiying Song, Suk Jin Ko, Chul Hoon Kim, Jin-Hyun Ahn, Kyung-Hee Chun, Jong In Yook, Ho-Geun Yoon.   

Abstract

Dysregulation of Wnt signaling has been implicated in tumorigenesis. The role of Transducin β-like proteins TBL1-TBLR1 in the promotion of Wnt/β-catenin-mediated oncogenesis has recently been emphasized; however, the molecular basis of activation of Wnt signaling by the corepressor TBL1-TBLR1 is incompletely understood. Here, we show that both TBL1 and TBLR1 are SUMOylated in a Wnt signaling-dependent manner, and that this modification is selectively reversed by SUMO-specific protease I (SENP1). SUMOylation dismissed TBL1-TBLR1 from the nuclear hormone receptor corepressor (NCoR) complex, increased recruitment of the TBL1-TBLR1-β-catenin complex to the promoter of Wnt target genes, and consequently led to activation of Wnt signaling. Conversely, SENP1 decreased formation of the TBL1-TBLR1-β-catenin complex, leading to inhibition of β-catenin-mediated transcription. Importantly, inhibition of SUMOylation significantly decreased the tumorigenicity of SW480 colon cancer cells. Thus, our data reveal a mechanism for activation of Wnt signaling via the SUMOylation-dependent disassembly of the corepressor complex.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21777810     DOI: 10.1016/j.molcel.2011.05.027

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  52 in total

Review 1.  TBL1XR1 in physiological and pathological states.

Authors:  Jian Yi Li; Garrett Daniels; Jing Wang; Xinmin Zhang
Journal:  Am J Clin Exp Urol       Date:  2015-04-25

2.  Autophagy in microglia degrades extracellular β-amyloid fibrils and regulates the NLRP3 inflammasome.

Authors:  Mi-Hyang Cho; Kwangmin Cho; Hoe-Jin Kang; Eun-Young Jeon; Hun-Sik Kim; Hyung-Joon Kwon; Hong-Mi Kim; Dong-Hou Kim; Seung-Yong Yoon
Journal:  Autophagy       Date:  2014-07-22       Impact factor: 16.016

3.  Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model.

Authors:  Courtney L Jones; Teena Bhatla; Roy Blum; Jinhua Wang; Steven W Paugh; Xin Wen; Wallace Bourgeois; Danielle S Bitterman; Elizabeth A Raetz; Debra J Morrison; David T Teachey; William E Evans; Michael J Garabedian; William L Carroll
Journal:  J Biol Chem       Date:  2014-07-25       Impact factor: 5.157

4.  Lymphatic metastasis-related TBL1XR1 enhances stemness and metastasis in gastric cancer stem-like cells by activating ERK1/2-SOX2 signaling.

Authors:  Jun Lu; Heejin Bang; Su Mi Kim; Soo-Jeong Cho; Hassan Ashktorab; Duane T Smoot; Chao-Hui Zheng; Sandra W Ryeom; Sam S Yoon; Changhwan Yoon; Jun Ho Lee
Journal:  Oncogene       Date:  2020-12-07       Impact factor: 9.867

5.  Exchange Factor TBL1 and Arginine Methyltransferase PRMT6 Cooperate in Protecting G Protein Pathway Suppressor 2 (GPS2) from Proteasomal Degradation.

Authors:  Jiawen Huang; M Dafne Cardamone; Holly E Johnson; Mathieu Neault; Michelle Chan; Z Elizabeth Floyd; Frédérick A Mallette; Valentina Perissi
Journal:  J Biol Chem       Date:  2015-06-12       Impact factor: 5.157

Review 6.  Nuclear receptor corepressor complexes in cancer: mechanism, function and regulation.

Authors:  Madeline M Wong; Chun Guo; Jinsong Zhang
Journal:  Am J Clin Exp Urol       Date:  2014-10-02

7.  Transducin (Beta)-Like 1 X-Linked Receptor 1 Correlates with Clinical Prognosis and Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma.

Authors:  Xuejun Kuang; Jiye Zhu; Zhao Peng; Jianjun Wang; Zhigang Chen
Journal:  Dig Dis Sci       Date:  2015-09-19       Impact factor: 3.199

8.  Nuclear TBLR1 as an ER corepressor promotes cell proliferation, migration and invasion in breast and ovarian cancer.

Authors:  Xinyu Wu; Yang Zhan; Xin Li; Jianjun Wei; Larion Santiago; Garrett Daniels; Fangming Deng; Xuelin Zhong; Luis Chiriboga; Ross Basch; Sheng Xiong; Yan Dong; Xinmin Zhang; Peng Lee
Journal:  Am J Cancer Res       Date:  2016-10-01       Impact factor: 6.166

9.  SUMO modification of menin.

Authors:  Zi-Jie Feng; Buddha Gurung; Guang-Hui Jin; Xiao-Lu Yang; Xian-Xin Hua
Journal:  Am J Cancer Res       Date:  2013-01-18       Impact factor: 6.166

10.  A girl with West syndrome and autistic features harboring a de novo TBL1XR1 mutation.

Authors:  Hirotomo Saitsu; Jun Tohyama; Tom Walsh; Mitsuhiro Kato; Yu Kobayashi; Ming Lee; Yoshinori Tsurusaki; Noriko Miyake; Yu-Ichi Goto; Ichizo Nishino; Akira Ohtake; Mary-Claire King; Naomichi Matsumoto
Journal:  J Hum Genet       Date:  2014-08-07       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.